Abstract
The impact of depression on quality of life (QOL) and social support has neither been well characterized in clinical samples of women with perimenopausal depression (PMD) nor have the relative contributions of depression and other menopausal symptoms (e.g., hot flushes) to declining QOL been clarified. In this study, we compared QOL measures, social support, and functional disability in PMD and non-depressed perimenopausal women. We evaluated women aged 40–60 years who presented with menstrual cycle irregularity, elevated plasma FSH levels, and met criteria for perimenopause. A structured clinical interview was administered to determine the presence or absence of major and minor depression. Outcome measures included the Quality of Life Enjoyment Scale Questionnaire, the Sheehan Disability Scale, the Global Assessment of Functioning, the Social Adjustment Scale, and the Duke Social Support Index. Kruskal-Wallis tests and ANOVAs were used to compare outcome measures. Ninety women with PMD and 51 control women participated in this study. Women with PMD reported significantly decreased QOL, social support, and adjustment and increased disability compared with non-depressed perimenopausal women. Neither perimenopausal reproductive status alone nor the presence of hot flushes had a significant negative impact on QOL measures. PMD is accompanied by significant reductions in QOL, social support, and disability similar to depression in women at other stages of life. PMD may also contribute to decreased QOL in community- or clinic-based samples of perimenopausal women. It remains unclear whether the clinical characteristics we identified reflect pre-existing risk factors for depression during the perimenopause or the effects of a current depression. Future clinical and treatment studies in perimenopausal women should distinguish depressed women when outcome measures include QOL.
Similar content being viewed by others
References
Archer DF, Sturdee DW, Baber R, de Villiers TJ, Pines A, Freedman RR, Gompel A, Hickey M, Hunter MS, Lobo RA, Lumsden MA, MacLennan AH, Maki P, Palacios S, Shah D, Villaseca P, Warren M (2011) Menopausal hot flushes and night sweats: where are we now? Climacteric 14:515–528
Bothwell S, Weissman MM (1977) Social impairments four years after an acute depressive episode. Am J Orthopsychiatry 47:231–237
Bromberger JT, di Scalea TL (2009) Longitudinal associations between depression and functioning in midlife women. Maturitas 64:145–159
Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF Jr (2007) Depressive symptoms during the menopausal transition: the study of women’s health across the nation (SWAN). J Affective Disord 103:267–272
Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset of depression during the menopausal transition. The Harvard study of moods and cycles. Arch Gen Psychiatry 63:385–390
Endicott J, Harrison W (1990) Daily rating of severity of problems form. New York State Psychiatric Institute, Department of Research Assessment and Training, New York
Endicott J, Lam RW, Hsu MA, Fayyad R, Boucher M, Guico-Pabia CJ (2014) Improvements in quality of life with desvenlafaxine 50 mg/d vs placebo in employed adults with major depressive disorder. J Affect Disord 166:307–314
Endicott J, Nee J, Cohen J, Halbreich U (1986) Premenstrual changes: patterns and correlates of daily ratings. J Affective Disord 10:127–135
Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29:321–326
First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-IP). Biometrics Research, New York State Psychiatric Institute, New York
Freeman EW, Sammel MD, Boorman DW, Zhang R (2013) The longitudinal pattern of depressive symptoms around natural menopause.
Freeman EW, Sammel MD, Lin H, Nelson DB (2006) Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63:375–382
Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L (2004) Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62–70
Goodger B, Byles J, Higganbotham N, Mishra G (1999) Assessment of a short scale to measure social support among older people. Aust N Z J Public Health 23:260–265
Grady D, Ettinger B, Tosteson ANA, Pressman A, Macer JL (2003) Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol 102:1233–1239
Greden JF (2001) The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 62(suppl 22):5–9
Grootenboer EM, Giltay EJ, van der Lem R, van VT, van der Wee NJ, Zitman FG (2012) Reliability and validity of the Global Assessment of Functioning Scale in clinical outpatients with depressive disorders. J Eval Clin Pract 18:502–507
Halbreich U, Kahn LS (2007) Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affective Disord 102:245–258
Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG (2003) Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348:1839–1854
Hays JC, Krishnan KR, George LK, Pieper CF, Flint EP, Blazer DG (1997) Psychosocial and physical correlates of chronic depression. Psychiatry Res 72:149–159
Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E (1996) A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24:161–175
Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, Price JL, Smith CL, Heindselman TL, Mount MK, Holdwick DJ Jr (2000) Reliability and validity of DSM-IV axis V. Am J Psychiatry 157:1858–1863
Hirschfeld RMA (2002) The mood disorder questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry 4:9–11
Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA (2002) Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the heart and estrogen/progestin replacement study (HERS) trial. J A M A 5:591–597
Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport MH (2013) A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res 22:585–596
Joffe H, Petrillo LF, Koukopoulos A, Viguera AC, Hirschberg A, Nonacs R, Somley B, Pasciullo E, White DP, Hall JE, Cohen LS (2011) Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 96:E1044–E1954
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R). J A M A 289:3095–3105
Koenig HG, Westlund RE, George LK, Hughes DC, Blazer DG, Hybels C (1993) Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. Psychosomatics 34:61–69
Kornstein SG, Clayton A, Bao W, Guico-Pabia CJ (2014) Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. Menopause 21:799–806
Lai CH (2011) Major depressive disorder: gender differences in symptoms, life quality, and sexual function. J Clin Psychopharmacol 31:39–44
Landerman R, George LK, Campbell RT, Blazer DG (1989) Alternative models of the stress buffering hypothesis. Am J Community Psychol 17:625–642
Matthews KA, Bromberger JT (2005) Does the menopausal transition affect health-related quality of life? Am J Med 118:25S–36S
Ness J, Aronow WS, Beck G (2006) Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 53:356–361
Ockene JK, Barad DH, Cochrane BB, Larson JC, Gass M, Wassertheil-Smoller S, Manson JE, Barnabei VM, Lane DS, Brzyski RG, Rosal MC, Wylie-Rosett J, Hays J (2005) Symptom experience after discontinuing use of estrogen plus progestin. J A M A 294:183–193
Ohayon MM (2006) Severe hot flashes are associated with chronic insomnia. Arch Intern Med 166:1262–1268
Pachana NA, Smith N, Watson M, McLaughlin D, Dobson A (2008) Responsiveness of the Duke Social Support sub-scales in older women. Age Ageing 37:666–672
Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA (2000) Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 61:101–109
Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R (2008) Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res 42:1042–1049
Rapaport MH, Clary C, Fayyad R, Endicott J (2005) Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162:1171–1178
Roberts RE, Vernon SW (1983) The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry 140:41–46
Rubinow DR, Johnson SL, Schmidt PJ, Girdler S, Gaynes B (2015) Efficacy of estradiol in perimenopausal depression: so much promise and so few answers. Depress Anxiety 32:539–549
Santen RJ et al (2010) Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95(7 Suppl 1):s1–s66
Schechter D, Endicott J, Nee J (2007) Quality of life of ‘normal’ controls: association with lifetime history of mental illness. Psychiatry Res 152:45–54
Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR (2015) Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry 72:714–726
Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414–420
Sheehan DV (2002) The management of panic disorder. J Clin Psychiatry 63(suppl 14):17–21
Sheehan KH, Sheehan DV (2008) Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 23:70–83
Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, Judd LL (1994) Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry 151:1777–1784
Silverstein B (2002) Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry 159:1051–1052
Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J (1999) An international study of the relation between somatic symptoms and depression. N Engl J Med 341:1329–1335
Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529–534
Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76:874–878
Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JBW, deGruy FVIII, Brody D, Davies M (1995) Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 study. J A M A 274:1511–1517
Spitzer RL, Kroenke K, Williams JBW (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J A M A 282:1737–1744
Spitzer RL, Williams JBW, Kroenke K, Hornyak R, McMurray J (2000) Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol 183:759–769
Stanaway FF, Kendig HL, Blyth FM, Cumming RG, Naganathan V, Waite LM (2011) Subjective social support in older male Italian-born immigrants in Australia. J Cross Cult Gerontol 26:205–220
Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes DF (2002) Hot flushes. Lancet 360:1851–1861
Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, Thompson K, Schmidt PJ (2008) A cross sectional evaluation of perimenopausal depression. J Clin Psychiatry 69:973–980
Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (2015) Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:3975–4011
Swan A, Watson HJ, Nathan PR (2009) Quality of life in depression: an important outcome measure in an outpatient cognitive-behavioural therapy group programme? Clin Psychol Psychother 16:485–496
Utian WH (2005) Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 47:1–10
Wang PS, Berglund P, Kessler RC (2000) Recent care of common mental disorders in the United States. J Gen Intern Med 15:284–292
Weissman A (1976) The discriminability of aspirin in arthritic and non arthritic rats. Pharmacol Biochem Behav 5:583–586
Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK (1978) Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 166:317–326
Wyrwich K, Harnam N, Revicki DA, Locklear JC, Svedsater H, Endicott J (2009) Assessing health-related quality of life in generalized anxiety disorder using the Quality of Life Enjoyment and Satisfaction questionnaire. Int Clin Psychopharmacol 24:289–295
Zollner YF, Acquadro C, Schaefer M (2005) Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 14:309–327
Acknowledgments
This work was written as part of Peter J. Schmidt’s official duties as a Government employee. This research was supported by the Intramural Research Program of the NIMH: NIMH Protocol 88-M-0131, NIMH Project # MH002537.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This protocol was approved by the Central Neuroscience Intramural Research Board, and written informed consent was obtained from each woman prior to entering the study.
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Wariso, B.A., Guerrieri, G.M., Thompson, K. et al. Depression during the menopause transition: impact on quality of life, social adjustment, and disability. Arch Womens Ment Health 20, 273–282 (2017). https://doi.org/10.1007/s00737-016-0701-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-016-0701-x